Inhibition of the glutamine transporter SNAT1 confers neuroprotection in mice by modulating the mTOR-autophagy system
Inhibition of the glutamine transporter SNAT1 confers neuroprotection in mice by modulating the mTOR-autophagy system
复制标题
DOI:
10.1038/s42003-019-0582-4
复制
发表时间:
2019-09
影响因子:
5.9
通讯作者:
D. Yamada;K. Kawabe;Ikue Tosa;Shunpei Tsukamoto;Ryota Nakazato;M. Kou;Koichi Fujikawa;Saki Nakamura-Saki-Nak
中科院分区:
文献类型:
--
作者:
D. Yamada;K. Kawabe;Ikue Tosa;Shunpei Tsukamoto;Ryota Nakazato;M. Kou;Koichi Fujikawa;Saki Nakamura-Saki-Nak
The pathophysiological role of mammalian target of rapamycin complex 1 (mTORC1) in neurodegenerative diseases is established, but possible therapeutic targets responsible for its activation in neurons must be explored. Here we identified solute carrier family 38a member 1 (SNAT1,Slc38a1) as a positive regulator of mTORC1 in neurons.Slc38a1flox/floxandSynapsin I-Cremice were crossed to generate mutant mice in whichSlc38a1was selectively deleted in neurons. Measurement of 2,3,5-triphenyltetrazolium chloride (TTC) or the MAP2-negative area in a mouse model of middle cerebral artery occlusion (MCAO) revealed thatSlc38a1deficiency decreased infarct size. We found a transient increase in the phosphorylation of p70S6k1 (pp70S6k1) and a suppressive effect of rapamycin on infarct size in MCAO mice. Autophagy inhibitors completely mitigated the suppressive effect of SNAT1 deficiency on neuronal cell death under in vitro stroke culture conditions. These results demonstrate that SNAT1 promoted ischemic brain damage via mTOR-autophagy system.